Larkspur Biosciences: Larkspur Biosciences Raises $35.5M in Financing

Larkspur Biosciences, a Watertown, MA-based biotechnology company building immunotherapies for cancer, raised $35.5M in funding. The round was led by Polaris Innovation Fund, 3E Bioventures Capital, and Takeda Ventures. Other investors included Creacion Ventures, Med-Fine Capital and Cornell University. The company intends to use the funds to focus on IND-enabling studies for its lead program, [...]The post Larkspur Biosciences Raises $35.5M in Financing appeared first on FinSMEs.